Category Archives : News

Home  >>  News

European Vaccination Initiative: TRANSVAC Launch Call for trainings in vaccinology

On June 7, 2018, Posted by , In News, By , With Comments Off on European Vaccination Initiative: TRANSVAC Launch Call for trainings in vaccinology

The first call for training modules has been launched, the deadline for application is 1 July 2018. Training scientists in vaccine research and development (R&D) is crucial in order to sustain Europe’s excellence in this field. The TRANSVAC2 Consortium has set up training modules at leading European centers that can…

DKFZ: What is the economic value of a life year?

On June 5, 2018, Posted by , In News, By , With Comments Off on DKFZ: What is the economic value of a life year?

Whether or not a medical treatment is added to the catalogue of services covered by a national health care scheme, in many jurisdictions largely depends on the economic assessment of its cost benefit ratio. The so-called “value of a statistical life year” (VSLY) is an important point of reference for…

DKFZ: Breast cancer – Microproteins essential for cancer growth

On June 1, 2018, Posted by , In News, By ,, , With Comments Off on DKFZ: Breast cancer – Microproteins essential for cancer growth

Breast cancer is one of the leading causes of death in women worldwide. In order to develop new therapies, it is necessary to understand exactly how breast cancer cells function. Scientists at the German Cancer Research Center have taken an important step in this direction: In tumor tissue from breast…

Heidelberg University: DFG Funding For Heidelberg Collaborative Research Centres

On May 24, 2018, Posted by , In News, By , With Comments Off on Heidelberg University: DFG Funding For Heidelberg Collaborative Research Centres

Ruperto Carola succeeds with three consortia in the latest approval round. Heidelberg University succeeded in gaining support from the German Research Foundation (DFG) in the latest approval round, receiving funding for three research networks. Two Collaborative Research Centres (CRC) in Heidelberg Medicine, the “Reactive Metabolites as a Cause of Diabetic…

EVI: European-African partnership to advance the development of a Leishmania vaccine

On May 16, 2018, Posted by , In News, With Comments Off on EVI: European-African partnership to advance the development of a Leishmania vaccine

Phase II clinical trials in Sudan of a therapeutic vaccine to prevent post kala azar dermal leishmaniasis to be supported by European & Developing Countries Clinical Trials Partnership Heidelberg, 16 May 2018 Fresh funding from the European & Developing Countries Clinical Trials Partnership (EDCTP) has been secured by a consortium…

DKFZ: “Universal antibodies” disarm various pathogens

On May 15, 2018, Posted by , In News, With Comments Off on DKFZ: “Universal antibodies” disarm various pathogens

Scientists from the German Cancer Research Center (DKFZ) have been studying how the immune system succeeds in keeping pathogens in check. For the first time, the researchers have now discovered antibodies that are capable of disarming not only one specific bacterium but a whole variety of microorganisms at once. The…

EMBL: Celgene joins Open Targets

On May 15, 2018, Posted by , In News, With Comments Off on EMBL: Celgene joins Open Targets

May 2nd 2018 Celgene has joined Open Targets, the public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation Open Targets was founded in 2014 by EMBL-EBI, GSK and the Wellcome Sanger Institute The Open Targets Platform allows researchers to investigate causal links between…

DKFZ/HD Uni Hospital/EMBL: Genetic analysis for certain childhood brain tumors soon a standard-of-care?

On May 14, 2018, Posted by , In News, By ,, , With Comments Off on DKFZ/HD Uni Hospital/EMBL: Genetic analysis for certain childhood brain tumors soon a standard-of-care?

An international team of researchers from the Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ), the European Molecular Biology Laboratory (EMBL) and the German Cancer Consortium (DKTK) together with colleagues at the St. Jude Children’s Research Hospital in Memphis and the Hospital for Sick Children in Toronto has summarized…

DKFZ: High science distinction for Michael Baumann

On May 9, 2018, Posted by , In News, By ,, , With Comments Off on DKFZ: High science distinction for Michael Baumann

At its 100th Annual Meeting, the American Radium Society honored Michael Baumann, Chairman and Scientific Director of the German Cancer Research Center (DKFZ), with the Janeway Gold Medal. The medal, which is awarded for outstanding contributions in cancer therapy, is one of the most prestigious distinctions in radiation oncology. Michael…

BioMed X and Merck extend research collaboration in oncology

On May 8, 2018, Posted by , In News, By ,, , With Comments Off on BioMed X and Merck extend research collaboration in oncology

BioMed X announced the start of a new research project in collaboration with Merck at its Innovation Center in Heidelberg. The new team will focus on the identification of novel approaches to exploit tumor-specific RNA splicing alterations for targeted cancer therapy.     Dr. Jan Mauer, who joined the BioMed X…